Oppenheimer & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$540K Sell
2,555
-10,809
-81% -$2.33M 0.01% 1162
2025
Q4
$2.75M Buy
13,364
+1,784
+15% +$336K 0.04% 454
2025
Q3
$1.82M Sell
11,580
-1,131
-9% -$175K 0.02% 639
2025
Q2
$2.14M Sell
12,711
-562
-4% -$83.4K 0.03% 554
2025
Q1
$1.83M Buy
13,273
+11,020
+489% +$1.4M 0.03% 572
2024
Q4
$266K Buy
2,253
+2
+0.1% +$233 ﹤0.01% 1329
2024
Q3
$249K Sell
2,251
-749
-25% -$78.3K ﹤0.01% 1323
2024
Q2
$295K Sell
3,000
-9,871
-77% -$1.01M ﹤0.01% 1197
2024
Q1
$1.44M Sell
12,871
-3,760
-23% -$406K 0.02% 617
2023
Q4
$1.68M Buy
16,631
+747
+5% +$74.1K 0.03% 548
2023
Q3
$1.38M Sell
15,884
-901
-5% -$81.4K 0.03% 570
2023
Q2
$1.59M Sell
16,785
-1
-0% -$84 0.03% 536
2023
Q1
$1.27M Sell
16,786
-172
-1% -$13K 0.03% 601
2022
Q4
$1.3M Sell
16,958
-1,594
-9% -$121K 0.03% 571
2022
Q3
$1.24M Sell
18,552
-514
-3% -$32.6K 0.03% 586
2022
Q2
$996K Buy
19,066
+15,447
+427% +$878K 0.02% 684
2022
Q1
$205K Sell
3,619
-914
-20% -$49K ﹤0.01% 1342
2021
Q4
$234K Buy
+4,533
New +$222K ﹤0.01% 1333
2021
Q3
Sell
-5,638
Closed -$322K 1497
2021
Q2
$322K Sell
5,638
-2,561
-31% -$150K 0.01% 1205
2021
Q1
$498K Buy
8,199
+21
+0.3% +$1.16K 0.01% 964
2020
Q4
$438K Buy
8,178
+107
+1% +$5.55K 0.01% 949
2020
Q3
$379K Buy
8,071
+1,488
+23% +$76.4K 0.01% 903
2020
Q2
$344K Sell
6,583
-13,800
-68% -$711K 0.01% 922
2020
Q1
$977K Buy
20,383
+13,890
+214% +$721K 0.03% 528
2019
Q4
$328K Buy
+6,493
New +$335K 0.01% 988
2019
Q3
Sell
-14,595
Closed -$688K 1272
2019
Q2
$688K Buy
14,595
+282
+2% +$13K 0.02% 710
2019
Q1
$689K Sell
14,313
-1,302
-8% -$65.2K 0.02% 699
2018
Q4
$696K Buy
15,615
+113
+0.7% +$5.89K 0.02% 632
2018
Q3
$837K Sell
15,502
-9,464
-38% -$484K 0.02% 655
2018
Q2
$1.22M Buy
24,966
+5,538
+29% +$314K 0.03% 522
2018
Q1
$1.22M Buy
+19,428
New +$1.33M 0.03% 539
2017
Q2
Sell
-4,939
Closed -$403K 1308
2017
Q1
$403K Sell
4,939
-887
-15% -$69.8K 0.01% 883
2016
Q4
$420K Sell
5,826
-102
-2% -$7.37K 0.01% 863
2016
Q3
$461K Buy
5,928
+1,635
+38% +$132K 0.01% 839
2016
Q2
$335K Sell
4,293
-712
-14% -$56.8K 0.01% 929
2016
Q1
$410K Sell
5,005
-36
-0.7% -$2.93K 0.01% 823
2015
Q4
$450K Buy
5,041
+923
+22% +$78.4K 0.01% 803
2015
Q3
$316K Sell
4,118
-193
-4% -$16.1K 0.01% 977
2015
Q2
$361K Buy
4,311
+1,887
+78% +$167K 0.01% 1022
2015
Q1
$219K Buy
+2,424
New +$209K 0.01% 1256
2014
Q4
Sell
-3,664
Closed -$275K 1402
2014
Q3
$275K Buy
3,664
+23
+0.6% +$1.67K 0.01% 1107
2014
Q2
$250K Buy
3,641
+501
+16% +$34.1K 0.01% 1148
2014
Q1
$220K Buy
+3,140
New +$218K 0.01% 1190

Other funds holding CAH

Oppenheimer & Co's CAH Position: Q1 2026 in Review

Oppenheimer & Co reduced its Cardinal Health (CAH) stake by 81% in Q1 2026, selling an estimated $2.33M and leaving 2,555 shares worth $540K. The position accounts for 0.01% of the portfolio, ranked #1162.

Oppenheimer & Co first reported a position in CAH in Q1 2014 and has held it in 43 quarters since. The position peaked at $2.75M in Q4 2025. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Oppenheimer & Co held 2,555 shares of Cardinal Health worth $540K as of Q1 2026.
  • Oppenheimer & Co sold 10,809 Cardinal Health shares in Q1 2026, an estimated $2.33M.
  • Cardinal Health made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1162 holding.
  • Oppenheimer & Co first reported a position in Cardinal Health in Q1 2014 and has held it in 43 quarters since.
  • Oppenheimer & Co's Cardinal Health position peaked at $2.75M in Q4 2025.
  • 1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.